Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Carmen Mestre-Durán"'
Autor:
María-José Felgueres, Gloria Esteso, Álvaro F. García-Jiménez, Ana Dopazo, Nacho Aguiló, Carmen Mestre-Durán, Luis Martínez-Piñeiro, Antonio Pérez-Martínez, Hugh T. Reyburn, Mar Valés-Gómez
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract The short-lived nature and heterogeneity of Natural Killer (NK) cells limit the development of NK cell-based therapies, despite their proven safety and efficacy against cancer. Here, we describe the biological basis, detailed phenotype and f
Externí odkaz:
https://doaj.org/article/bd24417e2d61481aba2a499fb276ab1b
Autor:
Beatriz Martín-Antonio, Belén Blanco, África González-Murillo, Laura Hidalgo, Jordi Minguillón, Gema Pérez-Chacón, Next Generation CART MAD Consortium, Lucía Fernández, Halin Bareke, Andrés París-Muñoz, Adriana Mañas, Cristina Aguirre-Portolés, Alfonso Navarro-Zapata, Carmen Mestre-Durán, Marta Ibáñez-Navarro, Laura Clares-Villa, Sara Naharro, Antonio Perez-Martinez, Marcos Aldea, María Gaibar, Javier Ruiz-Navarro, Manuel Izquierdo, Juan M. Zapata, África González Murillo, Elena García Sánchez, Jorge García Martínez, Alba Rubio San Simón, Blanca Herrero, Gonzalo García Aguilera, Beatriz Horcajo Morera, Manuel Ramírez Orellana, Belén Blanco-Durango, Anais Jiménez-Reinoso, Rodrigo Lázaro-Gorines, Ivana Zagorac, Antonio Tapia Galisteo, Ángel Ramirez-Fernández, Laura Díez-Alonso, Carmen Dominguez-Alonso, Ainhoa Erce-Llamazares, Oana Hangiu, Laura Rubio Pérez, Marina Gómez Rosel, Alejandro Segura Tudela, Javier Arroyo-Ródena, Luis Álvarez-Vallina, Miguel Ángel Rodríguez Milla, Patricia García Rodríguez, Beatriz Somovilla Crespo, Javier García-Castro, Esperanza Esquinas Tarifa, Juana Serrano-López, Pilar Llamas-Sillero, Beatriz Martin-Antonio
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Adoptive T cellular immunotherapies have emerged as relevant approaches for treating cancer patients who have relapsed or become refractory (R/R) to traditional cancer treatments. Chimeric antigen receptor (CAR) T-cell therapy has improved survival i
Externí odkaz:
https://doaj.org/article/49d95b3c222f4b7389eb0625d73c49df
Autor:
Marta Ibáñez-Navarro, Adrián Fernández, Adela Escudero, Gloria Esteso, Carmen Campos-Silva, Miguel Ángel Navarro-Aguadero, Alejandra Leivas, Beatriz Ruz Caracuel, Carlos Rodríguez-Antolín, Alejandra Ortiz, Alfonso Navarro-Zapata, Carmen Mestre-Durán, Manuel Izquierdo, María Balaguer-Pérez, Cristina Ferreras, Joaquín Martínez-López, Mar Valés-Gómez, Antonio Pérez-Martínez, Lucía Fernández
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionRefractory/relapsed pediatric acute leukemia are still clinically challenging and new therapeutic strategies are needed. Interactions between Natural Killer Group 2D (NKG2D) receptor, expressed in cytotoxic immune cells, and its ligands (
Externí odkaz:
https://doaj.org/article/a050597990ec4b1fb78353f27eb60db9
Autor:
Carmen Mestre-Durán, Carla Martín-Cortázar, Blanca García-Solís, Alicia Pernas, Lidia Pertíñez, Víctor Galán, Luisa Sisinni, Laura Clares-Villa, Alfonso Navarro-Zapata, Karima Al-Akioui, Adela Escudero, Cristina Ferreras, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
IntroductionNatural killer (NK) cells are lymphocytes from the innate immune system part of the first defense barrier against infected and transformed cells, representing 5%-15% of peripheral blood lymphocytes. The cytotoxic capacity of NK cells is c
Externí odkaz:
https://doaj.org/article/6e841a31af134385b8b7bf77ebe5d148
Autor:
Maria Vela, David Bueno, Pablo González-Navarro, Ariadna Brito, Lucía Fernández, Adela Escudero, Jaime Valentín, Carmen Mestre-Durán, Marina Arranz-Álvarez, Rebeca Pérez de Diego, Marta Mendiola, José Juan Pozo-Kreilinger, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Sarcoma is one of the most severe forms of pediatric cancer and current therapies -chemotherapy and surgery- fail to eradicate the disease in half of patients. Preclinical studies combining new therapeutic approaches can be useful to design better th
Externí odkaz:
https://doaj.org/article/a6a5c167d5b64a9e8698729c083fc625
Autor:
Karima Al-Akioui-Sanz, Bárbara Pascual-Miguel, Mariana Díaz-Almirón, Carmen Mestre-Durán, Alfonso Navarro-Zapata, Laura Clares-Villa, Carla Martín-Cortázar, José Luis Vicario, Miguel Ángel Moreno, Antonio Balas, Raquel De Paz, Jordi Minguillón, Antonio Pérez-Martínez, Cristina Ferreras
Publikováno v:
Cytotherapy. 25:330-340
Autor:
Antonio Perez, Cristina Ferreras, Clara Hernandez, Alejandro Martín-Quirós, Karima Al-Akioui, Marta Mora-Rillo, Fátima Ibáñez, Rosa Goterris, Raquel De Paz Arias, Pilar Guerra-García, Javier Queiruga-Parada, Pablo Molina, Merche Bou, Carmen Mestre-Durán, Alberto Borobia, Antonio J. Carcas, María Luisa Briones, Jose Luis Vicario, Miguel Ángel Moreno, Antonio Balas, Cristina Eguizábal, Bernat Soria, Carlos Solano
Publikováno v:
Transplantation and Cellular Therapy. 29:S63-S64
Autor:
Karima, Al-Akioui-Sanz, Bárbara, Pascual-Miguel, Mariana, Díaz-Almirón, Carmen, Mestre-Durán, Alfonso, Navarro-Zapata, Laura, Clares-Villa, Carla, Martín-Cortázar, José Luis, Vicario, Miguel Ángel, Moreno, Antonio, Balas, Raquel, De Paz, Jordi, Minguillón, Antonio, Pérez-Martínez, Cristina, Ferreras
Publikováno v:
Cytotherapy.
We have previously demonstrated the safety and feasibility of adoptive cell therapy with CD45RAWe performed a longitudinal analysis from previously severe acute respiratory syndrome coronavirus 2-infected and infection-naïve individuals covering 21
Autor:
Antonio Perez, María Ovidia López, Rocío González-Sacristán, Mercedes Gasior, Antonio Marcos, Raquel De Paz Arias, José María Alonso, Carmen Mestre-Durán, Karima Al-Akioui, Cristina Ferreras, Antonio Balas, Jose Luis Vicario, Carlos Solano, Belén Estébanez, Esther Ramos-Boluda, Carlos Jiménez, Francisco Hernández-Oliveros
Publikováno v:
Blood. 140:10484-10485
Autor:
Dolores Planelles, Paula Amat, Karima Al-Akioui, Carlos Solano, María Luisa Briones, Marta Mora-Rillo, Alejandro Martín-Quirós, Bernat Soria, Alberto M. Borobia, Cristina Ferreras, Carmen Mestre-Durán, Antonio J. Carcas, Rosa Goterris, Miguel Ángel Moreno, Antonio Balas, Javier Queiruga-Parada, Mercedes Gasior, Cristina Eguizabal, Raquel de Paz, Pilar Guerra-García, Jose L. Vicario, Antonio Pérez-Martínez, Merche Bou
Publikováno v:
Blood
Background: Adoptive cell immunotherapies for opportunistic virus in immunocompromised patients using haploidentical memory T cells have shown to be safe and effective. Since severe cases of COVID-19 present a dysregulated immune system with T cell l